2015
Associations between Deceased-Donor Urine Injury Biomarkers and Kidney Transplant Outcomes
Reese PP, Hall IE, Weng FL, Schröppel B, Doshi MD, Hasz RD, Thiessen-Philbrook H, Ficek J, Rao V, Murray P, Lin H, Parikh CR. Associations between Deceased-Donor Urine Injury Biomarkers and Kidney Transplant Outcomes. Journal Of The American Society Of Nephrology 2015, 27: 1534-1543. PMID: 26374609, PMCID: PMC4849827, DOI: 10.1681/asn.2015040345.Peer-Reviewed Original ResearchConceptsDelayed graft functionRecipient delayed graft functionKidney injury molecule-1Graft functionInjury biomarkersDonor AKIDeceased donor organ qualityLiver-type fatty acidEarly allograft functionL-FABP concentrationRecipient renal functionUrinary NGAL concentrationsKidney transplant recipientsInjury molecule-1Kidney transplant outcomesAllograft functionUrinary NGALKidney injuryTransplant outcomesTransplant recipientsNGAL concentrationsRenal functionNeutrophil gelatinaseDeceased donorsIL-18
2006
Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease
Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease. JAMA 2006, 296: 1377-1384. PMID: 16985230, DOI: 10.1001/jama.296.11.1377.Peer-Reviewed Original ResearchConceptsChronic congestive heart failureCongestive heart failureRenal diseaseRenal functionHeart failureSubgroup analysisCardiovascular diseaseCardiology/American Heart Association guidelinesAmerican Heart Association guidelinesAldosterone system antagonistsBaseline renal functionHeart Association guidelinesCardiovascular disease trialsCurrent American CollegeRandomized Controlled TrialsAcute myocardial infarctionEffects of interventionsRepresentation of patientsOriginal articlesBaseline characteristicsCardiovascular mortalityPatient characteristicsControlled TrialsPrognostic featuresMyocardial infarction